Black Rock Inc. Endra Life Sciences Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.19 - $0.45 $19,304 - $45,720	-101,602 Reduced 98.02%	2,057 $0
Q1 2022 May 12, 2022	SELL	$0.36 - $0.77 $1,782 - $3,811	-4,950 Reduced 4.56%	103,659 $40,000
Q4 2021 Feb 10, 2022	BUY	$0.69 - $1.73 $3,316 - $8,316	4,807 Added 4.63%	108,609 $75,000
Q3 2021 Nov 09, 2021	SELL	$1.38 - $2.15 $3,035 - $4,730	-2,200 Reduced 2.08%	103,802 $180,000
Q2 2021 Aug 11, 2021	BUY	$1.98 - $2.74 $209,883 - $290,445	106,002 New	106,002 $231,000

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $353M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.